4The Office of Fair Trading. The pharmaceutical price regulation scheme.An OFT market study [EB/OL] . http ://www. oft. gov. uk/NR/rdonlyres/7CTATCC1 - F320 - 4978- AC64 - F67F9AB67B6C/ 0/ oft885.pdf. 2007 03.2007- 12- 05.
5House of Commons. The influence of the pharmaceutical industry [ R ] . 2005.
6Department of Health and the Association of the British Pharmaceutical Industry. Pharmaceutical price regula tion scheme [ EB/OL ]. htt p ://www. dh. gov. uk/pprs. 2004. 2007 - 12 - 05.
7Kucher Eckhard.The Euro and Pharmaceutical Pricing in Europe [ J ].Spectrum Life Sciences,2000,(3):3 - 10.
8Perleth M. Health policy [J]. Thorac Cardiovasc Surg, 1999,12(46):105-126
9Dumoulin Jerome. Incentives and Pharmaceutical Reimbursement Reforms in Spain [J]. International Journal of Biotechnology, 2004, 3(4): 338-349.
10Jaume Puig-Junoy. Phannacoeconomics and Policy Decisions: The Australian Health Care System [J].Health Policy, 2004 (67): 149- 165.
